环加成
合成子
区域选择性
化学
钯
催化作用
反应性(心理学)
组合化学
偶联反应
立体化学
有机化学
医学
病理
替代医学
作者
Long Li,Pengfei Luo,Yu-Hua Deng,Zhihui Shao
标识
DOI:10.1002/anie.201901511
摘要
The first Pd-catalyzed asymmetric allenylic [4+1] cycloaddition was successfully developed. Alternatively, tuning the Pd catalyst switched the reactivity toward an unprecedented [4+3] cycloaddition/cross-coupling. Ligands play a vital role in controlling the reaction pathway, allowing highly selective access to different products from identical substrates. Biological evaluation of the obtained compounds led to the discovery of new antitumor targets. A possible mechanism is proposed, suggesting two interesting catalytic cycles for the cycloaddition with palladium-butadienyls. This study also demonstrated the potential and utility of allenic esters as 1,4-biselectrophiles and C4 synthons for participating in cycloaddition reactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI